Recombinant epidermal growth factor derivative - Uni-Bio Science Group

Drug Profile

Recombinant epidermal growth factor derivative - Uni-Bio Science Group

Alternative Names: GeneSoft; rEGF derivative - Uni-Bio Science Group

Latest Information Update: 21 Nov 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Uni-Bio Science Group
  • Class Antiulcers; Growth factors
  • Mechanism of Action Epidermal growth factor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Corneal ulcer

Most Recent Events

  • 14 Nov 2016 Uni-Bio Science Group and China Resources Zizhu Pharmaceutical agree to co-promote Recombinant epidermal growth factor derivative (GeneSoft®) in China for Corneal ulcer
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top